GelSana Selected for CLS FAST Spring 2023 Cohort
GelSana is honored and excited to be selected as one of the cohort companies for California…
News
Read MoreGelSana Selected for CLS FAST Spring 2023 Cohort
GelSana Presents at Destination Startup in Denver, CO, February 2023
GelSana was honored to be one of the companies selected to pitch at Destination Startup 2023.…
Melissa Krebs Interviewed for Academic Female Founders Interview Series by Osage University Partners, December 2022
Melissa Krebs, CEO and Founder of GelSana, was honored to be interviewed by Osage University Partners…
GelSana Attends Diabetic Foot Conference (DF Con) in Los Angeles, September 2022!
GelSana attended Diabetic Foot Conference (DF Con) in sunny Los Angeles in September 2022. So many…
GelSana Presents at Colorado BioScience Association Investor and Partnering Conference in Vail, CO, September 2022
GelSana was thrilled to be selected as one of the presenting companies at Colorado BioScience Association’s…
GelSana Wins at the TechConnect World Innovation Conference 2022 Medical Innovation Challenge!
GelSana Therapeutics was selected to participate in the TechConnect World Innovation Conference 2022 Medical Innovation Challenge.…
GelSana Takes First Place at the 2022 Montfort College of Business Entrepreneurial Challenge
The University of Northern Colorado’s Monfort College of Business has announced the winners of the 2022 Entrepreneurial Challenge.…
GelSana awarded an Advanced Industries Accelerator grant
The Advanced Industries Accelerator (AIA) Program announced that 22 Colorado companies and five researchers were approved to receive Proof…
Colorado BioScience Association Highlights Health Innovators at Innovation Forward: Forum + Awards Celebration
LightDeck Diagnostics Named Company of the Year, Artisan Bio Honored as Rising Star of the Year…